About Deerfield

Launched in 1994, Deerfield Management Company is an investment firm dedicated to advancing healthcare through information, investment, and philanthropy—all toward the end goal of cures for disease, improved quality of life, and reduced cost of care.

Read More

Supporting companies across the healthcare ecosystem with flexible funding models…

Read More

Delivering market research to the Deerfield team, its portfolio companies and other partners.

Read More ---

A New York City-based not-for-profit devoted to advancing innovative health care initiatives.

Read More
Research Collaborations

Deerfield partners with leading academic research centers, providing critical funding and expertise to further sustain and accelerate the commercialization of discoveries toward meaningful societal impact by advancing cures for disease.

Read More
Strategic Partners

As a strategic partner, Deerfield offers capital, scientific expertise, business operating support, and unique access to innovation.

Deerfield Foundation

The Deerfield Foundation is a New York City-based not-for-profit organization whose mission is to improve health, accelerate innovation and promote human equity.

Read More Meet the Foundation Team
Cure Campus

Cure is a 12-story innovations campus in New York City that intends to bring together innovators from academia, government, industry, and the not-for-profit sectors to advance human health and accelerate the fight against disease.

Read More Meet the Cure Team Join the Cure Email List
Cure Programming

Cure has a series of expert lectures intended to advance thought in healthcare, management, innovation, policy, and other relevant subjects. This fosters growth and education for those at Cure and its guests.

Cure Symposium Calendar

Bryan Sendrowski

Bryan Sendrowski is a Partner and Head of Corporate Finance, and joined the Firm in 2012. Mr. Sendrowski leads the External Operations team and is responsible for the day-to-day oversight and management of certain investments in Deerfield’s Private Design and Healthcare Innovation Funds. He assumed the Head of Corporate Finance role in early 2021, and in this position, he oversees the financial management and related operating activities of several Deerfield legal entities, including Deerfield Management Company. Prior to joining Deerfield, Mr. Sendrowski was Chief Financial Officer of New American Therapeutics, a specialty pharmaceutical company that was funded and facilitated by Deerfield’s Private Design Funds. Before New American Therapeutics, he was Chief Financial Officer at Akrimax Pharmaceuticals, as well as Vice President and Controller of Reliant Pharmaceuticals. Mr. Sendrowski also previously served as a Senior Manager in the financial statement audit practice of KPMG with responsibility for the management of public and private company audits. He received his B.A. from Pace University and is licensed (inactive) as a Certified Public Accountant in the state of New Jersey.